scholarly article | Q13442814 |
P356 | DOI | 10.1007/S11010-013-1925-Y |
P698 | PubMed publication ID | 24347177 |
P2093 | author name string | Sheng-Quan Zhang | |
Lei Li | |||
Fang Wang | |||
Xin Luo | |||
Bo Jia | |||
Feng-Wei Cheng | |||
P2860 | cites work | Human TLR7 or TLR8 independently confer responsiveness to the antiviral compound R-848 | Q24298297 |
Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8 | Q24310398 | ||
Generation of secretable and nonsecretable interleukin 15 isoforms through alternate usage of signal peptides | Q24647708 | ||
A human homologue of the Drosophila Toll protein signals activation of adaptive immunity | Q28131769 | ||
Imiquimod applied topically: a novel immune response modifier and new class of drug | Q28140002 | ||
Interleukin 15 as a promising candidate for tumor immunotherapy | Q28236508 | ||
Review Article Imiquimod applied topically: a novel immune response modifier and new class of drug | Q29396548 | ||
Human papillomavirus is a necessary cause of invasive cervical cancer worldwide | Q29617514 | ||
Cloning and characterization of a sub-family of human toll-like receptors: hTLR7, hTLR8 and hTLR9. | Q33920505 | ||
Toll-like receptor 4 signaling in liver injury and hepatic fibrogenesis | Q34321742 | ||
Cytotoxic T lymphocytes: all roads lead to death | Q34716318 | ||
Tumour growth inhibition by an imidazoquinoline is associated with c-Myc down-regulation in urothelial cell carcinoma | Q34744159 | ||
Host innate immune receptors and beyond: making sense of microbial infections | Q34785533 | ||
Imiquimod and the imidazoquinolones: mechanism of action and therapeutic potential | Q35015851 | ||
Overexpression of TLR3, TLR4, TLR7 and TLR9 in esophageal squamous cell carcinoma | Q35235996 | ||
Toll-like receptors, inflammation and cancer | Q36254028 | ||
Toll-like receptor 7 regulates pancreatic carcinogenesis in mice and humans | Q36357873 | ||
Toll-like receptor agonists in the treatment of chronic lymphocytic leukemia | Q36635059 | ||
Toll-like receptors: key activators of leucocytes and regulator of haematopoiesis. | Q36952605 | ||
TLR signaling by tumor and immune cells: a double-edged sword | Q37051027 | ||
The use of TLR7 and TLR8 ligands for the enhancement of cancer immunotherapy | Q37243188 | ||
Papillomaviruses in the causation of human cancers - a brief historical account | Q37365856 | ||
The TLR7 agonists imiquimod and gardiquimod improve DC-based immunotherapy for melanoma in mice | Q37728656 | ||
Important aspects of Toll-like receptors, ligands and their signaling pathways | Q37769153 | ||
The role of interleukin-6 in gynaecological malignancies. | Q38048977 | ||
Role of phosphoinositide 3-kinase in activation of ras and mitogen-activated protein kinase by epidermal growth factor | Q39551502 | ||
Osteopontin promotes hepatocellular carcinoma invasion by up-regulating MMP-2 and uPA expression | Q39628244 | ||
Impaired expression and function of toll-like receptor 7 in hepatitis C virus infection in human hepatoma cells | Q39788612 | ||
PTEN regulates angiogenesis through PI3K/Akt/VEGF signaling pathway in human pancreatic cancer cells | Q39852386 | ||
Toll-like receptor 7 and MyD88 knockdown by lentivirus-mediated RNA interference to porcine dendritic cell subsets. | Q40165149 | ||
Tumor-selective induction of apoptosis and the small-molecule immune response modifier imiquimod | Q42445719 | ||
Hepatocyte growth factor protects endothelial progenitor cell from damage of low-density lipoprotein cholesterol via the PI3K/Akt signaling pathway | Q43291021 | ||
Toll-like receptor-7 tolerizes malignant B cells and enhances killing by cytotoxic agents | Q43881315 | ||
Tissue-specific mRNA expression profiles of human toll-like receptors and related genes | Q44407781 | ||
MMP-2 and TIMP-1 are derived from, not in response to, pancreatic cancer | Q45882622 | ||
Type IV collagenase (matrix metalloproteinase-2 and -9) in prostate cancer. | Q54702586 | ||
Association between Toll-Like Receptor Gene Cluster (TLR6, TLR1, and TLR10) and Prostate Cancer | Q58033496 | ||
Imbalance of expression of matrix metalloproteinases (MMPs) and tissue inhibitors of the matrix metalloproteinases (TIMPs) in human pancreatic carcinoma | Q73828612 | ||
Amentoflavone inhibits experimental tumor metastasis through a regulatory mechanism involving MMP-2, MMP-9, prolyl hydroxylase, lysyl oxidase, VEGF, ERK-1, ERK-2, STAT-1, NM23 and cytokines in lung tissues of C57BL/6 mice | Q81753761 | ||
Regulation of Toll-like receptor-induced chemokine production in murine dendritic cells by mitogen-activated protein kinases | Q84184149 | ||
P433 | issue | 1-2 | |
P921 | main subject | toll-like receptor | Q408004 |
P304 | page(s) | 43-49 | |
P577 | publication date | 2013-12-18 | |
P1433 | published in | Molecular and Cellular Biochemistry | Q1573176 |
P1476 | title | The activation of TLR7 regulates the expression of VEGF, TIMP1, MMP2, IL-6, and IL-15 in Hela cells | |
P478 | volume | 389 |
Q40145775 | Condition responsive nanoparticles for managing infection and inflammation in keratitis. |
Q54094657 | Effect of TLR4 on the growth of SiHa human cervical cancer cells via the MyD88-TRAF6-TAK1 and NF-κB-cyclin D1-STAT3 signaling pathways. |
Q37734788 | Inhibition of the TGFβ signalling pathway by cGMP and cGMP-dependent kinase I in renal fibrosis |
Q37665498 | Lipid rafts promote liver cancer cell proliferation and migration by up-regulation of TLR7 expression |
Q37012686 | Nucleic acid-sensing toll-like receptors 3, 7 and 8 in esophageal epithelium, barrett's esophagus, dysplasia and adenocarcinoma |
Q41228349 | Progression of pathology in PINK1-deficient mouse brain from splicing via ubiquitination, ER stress, and mitophagy changes to neuroinflammation |
Q33678336 | Toll-like receptor 7 deficiency protects apolipoprotein E-deficient mice from diet-induced atherosclerosis |